Pfizer Inc. (PFE)
PFENYSEBiotechnology: Pharmaceutical Preparations
$29.27
-0.1199 (-0.41%) today
Closed, Nov 9, 4:02 PM ET
- Market cap
- $166.66bn
- P/E
- 9.6
- EPS, last 4 quarters
- $3.05
- Dividend yield
- –
- Day range
- –
- 52-week range
- $23.62 to $31.44
- Average volume
- 27.47m
- Previous close
- $29.39
Analysts
22 coveringHold7 buy, 14 hold, 1 sell
Targets a year out average $30.28, +3.5% from here
Earnings
next estimate $0.6900Next report
Dec 2025
+15.8%
Mar 2026
+5.6%
Jun 2026
+13.2%
Sep 2026
+20.8%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $17.56bn | $14.45bn | $15.03bn | $16.58bn |
| Gross profit | $12.29bn | $10.90bn | $10.94bn | $12.55bn |
| Operating income | $2.87bn | $4.03bn | $3.06bn | $3.67bn |
| Net income | -$1.64bn | $2.70bn | -$238.00m | $3.25bn |
Last four quarters: revenue $63.62bn, margin 6.4%, free cash flow $11.79bn
News
8 latest- Can Moderna's First Cancer Therapy Win FDA Approval in 2027?Zacks · 11 hours ago
- Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028The Motley Fool · 13 hours ago
- Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks · 15 hours ago
- Will Bristol Myers' Growth Brands Offset Eliquis Headwinds?Zacks · 16 hours ago
- Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity TrialsThe Motley Fool · 2 days ago
- After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.The Motley Fool · 3 days ago
- 3 High-Yield Healthcare Stocks to Buy With $1,000 and Hold Through Any MarketThe Motley Fool · 3 days ago
- NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs DeclineZacks · 4 days ago
The company
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For over 175 years, we have worked to make a difference for all who rely on us.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- pfizer.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.